Effects of Esketamine Combined with Remimazolam on Postoperative Acute Sleep Disturbance in Patients Undergoing Gynecological Surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2500099972

Enrollment

Unknown

Registered

2025-04-01

Start date

2025-05-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Interventions

Esketamine Group:Esketamine

Control Group:NA

Remimazolam Group:remimazolam

Remimazolam + Esketamine Group:Remimazolam + Esketamine

Eligibility

Sex/Gender

Female

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Informed consent; 18~65 years old; 2.Scheduled for hysterectomy;

Exclusion criteria

Exclusion criteria: 1.Unable to or refuse to obtain informed consent; 2.Patients with severe neuropsychiatric, cardiovascular, and respiratory disorders; 3.Transfer to ICU after operation;

Design outcomes

Primary

Measure	Time frame
Sleep condition;	—

Secondary

Measure	Time frame
Pain condition;	—

Countries

China

Contacts

Public ContactYuanBo Ni

the First People's Hospital of Nantong

nyb2837468944@163.com+86 182 5271 9571

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026